Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms
Federico Gatto, Federica Barbieri, Marica Arvigo, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3940-3940
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management
Daniela Espósito, César Luiz Boguszewski, Annamaria Colao, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 9, pp. 541-552
Closed Access | Times Cited: 9
Differential Impact of Medical Therapies for Acromegaly on Glucose Metabolism
Federico Gatto, Anna Arecco, Jessica Amarù, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 465-465
Open Access | Times Cited: 1
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
Maria J. Klomp, Simone U. Dalm, Marion de Jong, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 3, pp. 495-510
Open Access | Times Cited: 53
Role of Somatostatin Signalling in Neuroendocrine Tumours
Olesja Rogoza, Kaspars Megnis, Marija Kudrjavceva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1447-1447
Open Access | Times Cited: 34
The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review
Aldona Kasprzak, Agnieszka Geltz
Biomedicines (2024) Vol. 12, Iss. 3, pp. 578-578
Open Access | Times Cited: 4
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis
Massimo Milione, Patrick Maisonneuve, Federica Grillo, et al.
Neuroendocrinology (2020) Vol. 111, Iss. 5, pp. 475-489
Open Access | Times Cited: 28
Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): Review of the Literature of a Rare Cause of Hyperinsulinemic Hypoglycemia
Martin Philipp Dieterle, Ayman Husari, Sophie Nicole Prozmann, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1732-1732
Open Access | Times Cited: 10
Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogs
Giuliana Corica, Rosa Pirchio, Angelo Milioto, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 3, pp. 683-697
Closed Access | Times Cited: 10
miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
Daniel G. Henriques, Renan Lyra Miranda, Rômulo Sperduto Dezonne, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2875-2875
Open Access | Times Cited: 9
Patterns of Gene Expression Profiles Associated with Colorectal Cancer in Colorectal Mucosa by Using Machine Learning Methods
Jing Xin Ren, Lei Chen, Wei Guo, et al.
Combinatorial Chemistry & High Throughput Screening (2023) Vol. 27, Iss. 19, pp. 2921-2934
Closed Access | Times Cited: 9
Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators
Saptarshi Mallick, Jayati Chakrabarti, Jennifer Eschbacher, et al.
Translational research (2023) Vol. 256, pp. 56-72
Open Access | Times Cited: 8
Cortisol as a Target for Treating Mental Disorders: A Promising Avenue for Therapy
Vijay K. Patel, Aayush Vaishnaw, Ekta Shirbhate, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 6, pp. 588-600
Closed Access | Times Cited: 8
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells
Roberto Würth, Stefano Thellung, Alessandro Corsaro, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 23
Somatostatin, a Presynaptic Modulator of Glutamatergic Signal in the Central Nervous System
Anna Pittaluga, Alessandra Roggeri, G Vallarino, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5864-5864
Open Access | Times Cited: 19
Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant
Rosario Pivonello, Pamela N. Münster, Massimo Terzolo, et al.
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 12
<p>Octreotide-Resistant Acromegaly: Challenges and Solutions</p>
Giuliana Corica, Marco Ceraudo, Claudia Campana, et al.
Therapeutics and Clinical Risk Management (2020) Vol. Volume 16, pp. 379-391
Open Access | Times Cited: 17
Somatostatin Primes Endothelial Cells for Agonist-Induced Hyperpermeability and Angiogenesis In Vitro
Muhammad Aslam, Hafiza Idrees, Péter Ferdinándy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3098-3098
Open Access | Times Cited: 10
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus
Concetta Sciammarella, Amalia Luce, Ferdinando Riccardi, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 15
Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
María Isabel del Olmo-García, S. Prado-Wohlwend, A. Torregrosa Andrés, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1810-1810
Open Access | Times Cited: 13
Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors
Rosaria Maddalena Ruggeri, Irene Aini, Stefano Gay, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 25, Iss. 2, pp. 383-398
Closed Access | Times Cited: 5
Somatostatin and Its Receptor System in Colorectal Cancer
Aldona Kasprzak
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1743-1743
Open Access | Times Cited: 12
The Role of Receptor–Ligand Interaction in Somatostatin Signaling Pathways: Implications for Neuroendocrine Tumors
Agnieszka Milewska-Kranc, Jarosław B. Ćwikła, Agnieszka Kolasińska-Ćwikła
Cancers (2023) Vol. 16, Iss. 1, pp. 116-116
Open Access | Times Cited: 4
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives
E Lauricella, Sofija Vilisova, Nada Chaoul, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-14
Closed Access | Times Cited: 1
Digital quantification of somatostatin receptor subtype 2a immunostaining: a validation study
Claudia Campana, Peter M. van Koetsveld, Richard A. Feelders, et al.
European Journal of Endocrinology (2022) Vol. 187, Iss. 3, pp. 399-411
Open Access | Times Cited: 7
Potential markers of disease behavior in acromegaly and gigantism
Laura C. Hernández‐Ramírez
Expert Review of Endocrinology & Metabolism (2020) Vol. 15, Iss. 3, pp. 171-183
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top